Debut Plus

₹24.87

▲ +0.18 +0.73%

26 Oct 2026

BSE Listed

Beryl Drugs Ltd. (524606)

Volume: 2,726Avg Vol 1W: 877Avg Vol 1M: 2,40252W Range:₹15.92₹27.9
BSE www.beryldrugs.com AI Report
Key Ratios
Checked just now
Market Cap₹13 Cr
Current Price₹24.87
Previous Close₹24.69
High / Low (52w)₹27.9 / ₹15.92
Volume2,726
Avg Vol (1W)877
Avg Vol (1M)2,402
Stock P/E20.22
Book Value₹19.45
Dividend Yield0%
ROE429.63%
ROA414.44%
Revenue (TTM)—
Revenue Growth—
Profit Margin290.67%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹1.23
P/B1.28
Debt / Equity0.34
50 DMA₹24.02
200 DMA₹22.41
Day change+0.73%
Price Chart
₹24.87▲ 8.18% · 1Y
₹26₹171.0L
2025-10-27
2026-10-26

20-day avg volume: 3K shares

Pros
  • Healthy return on equity of 429.6%.
  • Company is almost debt-free.
Cons
  • Revenue fell 14% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹8 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹13 Cr₹13 Cr₹14 Cr₹15 Cr₹27 Cr₹27 Cr₹23 Cr₹19 Cr
EBITDA₹1 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹1 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr
EPS1.160.090.47-1.31.511.521.140.84
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹15 Cr₹17 Cr₹19 Cr₹18 Cr₹18 Cr₹17 Cr₹16 Cr₹15 Cr
Total Liabilities₹7 Cr₹9 Cr₹11 Cr₹11 Cr₹9 Cr₹9 Cr₹6 Cr₹5 Cr
Equity₹8 Cr₹8 Cr₹8 Cr₹7 Cr₹8 Cr₹9 Cr₹10 Cr₹10 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr
Investing₹0 Cr₹1 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-2 Cr
Financing₹-1 Cr₹0 Cr₹-1 Cr₹0 Cr₹-2 Cr₹-2 Cr
Free Cash Flow₹0 Cr₹0 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr
Shareholding
Promoter 27.97% Institutions 0% Public 72.03%
Efficiency & Working Capital
ROCE7.6%
Interest Coverage2.7
Dividend Payout—
Debtor Days41 d
Inventory Days61 d
Payable Days28 d
Cash Conversion Cycle73 d
Working Capital Days101 d
Shareholding Details

As of 2026-09-30

Promoter28%
FII0%
DII0%
Institutions0%
Public72%
Promoter Pledge0%
No. of Shareholders7,296
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters26.4%26.4%26.4%26.4%26.4%26.4%26.4%26.4%26.4%27.5%27.8%28%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public73.6%73.6%73.6%73.6%73.6%73.6%73.6%73.6%73.6%72.5%72.2%72%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders6,8527,2577,3257,3647,4297,4317,4157,4467,4097,3497,3097,296
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sanjay SethiShareholding of Promoter and Promoter Group10.9%5,51,800
Sudhir SethiShareholding of Promoter and Promoter Group10.2%5,18,928
Sangita SethiShareholding of Promoter and Promoter Group3.8%1,91,935
Pradeep Kumar JainPublic Shareholding3.5%1,78,600
Soniya SethiShareholding of Promoter and Promoter Group3.1%1,55,896
Narendrakumar Bhagwandas GuptaPublic Shareholding2.8%1,40,000
Mayank SiyalPublic Shareholding2.1%1,04,865
Jinesh JosephPublic Shareholding1.7%84,796
Punjabhai Keshavbhai JadejaPublic Shareholding1.2%62,511
Ram Babu VijayPublic Shareholding1.2%60,250
Simimon Kallupurackal JobyPublic Shareholding1.1%53,335
Board of Directors
NameDesignationYear
Sudhir SethiChairman & Non Executive Dir.2025
Sanjay SethiManaging Director2025
Abhinav NaikIndependent Non Exe. Director2025
Shreya SarafIndependent Non Exe. Director2025
Neha SharmaCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101055
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-11Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000011
2026000000
2026000011
Insider / Designated-Person Trades

15 recent disclosure(s)

SUDHIR SETHIAcquisition · 4,809
SUDHIR SETHIAcquisition · 3,000
SUDHIR SETHIAcquisition · 6,950
SUDHIR SETHIAcquisition · 30
SUDHIR SETHIAcquisition · 3,482
SUDHIR SETHIAcquisition · 4,682
Substantial Acquisitions (SAST)

10 disclosure(s)

Market18/08/2026 · 4,809
Market17/08/2026 · 3,000
Market25/06/2026 · 6,950
Market10/06/2026 · 30
Market09/06/2026 · 3,482
Market08/06/2026 · 4,682
Company Information
Incorporated1993
ChairmanSudhir Sethi
AuditorSubhash Chand Jain Anurag & Associates
Investor Email[email protected]
🌐 www.beryldrugs.com ↗

📍 29 Neer Nagar Mayank Water, Park Road Bicholi, Indore, Madhya Pradesh, 452016

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Hemo Organic LimitedJaysynth Orgochem LimitedAeonx Digital Technology Ltd.AksharChemBandaram Pharma Packtech Ltd.Adline Chem Lab LimitedIEL LimitediStreet Network LimitedGagan Gases Ltd.Parker Agrochem Exports LimitedShukra Pharmaceuticals LimitedOxygenta Pharmaceutical LimitedAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search